Events

Recall of EMIT ETHOSUXIMIDE ASSAY

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by SIEMENS HEALTHCARE LIMITED.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    30931
  • Event Risk Class
    III
  • Event Initiated Date
    2016-11-15
  • Event Country
    Canada
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Siemens healthcare diagnostics has confirmed the emit ethosuximide assay (etho) reagent lot h1 fails to calibrate on the viva-e v-twin viva proe and au clinical chemistry systems (au analyzers) when tested with the emit antiepileptic drug (aed) calibrator lot h1. the calibration failure will not allow the user to accept and store the calibration. all other in date emit ethosuximide lots successfully pass calibration when tested with the emit aed calibrator lot h1.

Device

EMIT ETHOSUXIMIDE ASSAY
  • Model / Serial
    Model Catalog: 6E119UL (Lot serial: H1)
  • Product Description
    Emit Ethosuximide Assay
  • Manufacturer
    SIEMENS HEALTHCARE LIMITED

Manufacturer

SIEMENS HEALTHCARE LIMITED
  • Manufacturer Address
    OAKVILLE
  • Manufacturer Parent Company (2017)
    Siemens Ag
  • Source
    HC